Do the changes in the serum levels of IL-2, IL-4, TNFα, and IL-6 reflect the inflammatory activity in the patients with post-ERCP pancreatitis?

Clinical and Developmental Immunology

Volumn 2008, Issue , 2008, Pages

  Kilciler, Guldem ^a   Musabak, Ugur ^a   Bagci, Sait ^a   Yesilova, Zeki ^a   Tuzun, Ahmet ^a   Uygun, Ahmet ^a   Gulsen, Mustafa ^a   Oren, Sema ^a   Oktenli, Cagatay ^b   Karaeren, Necmettin ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

^b GATA HAYDARPASA TRAINING HOSPITAL   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLASE; C REACTIVE PROTEIN; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE;

ACUTE PANCREATITIS; AMYLASE BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; EPIGASTRIC PAIN; FEMALE; HUMAN; HYPERAMYLASEMIA; INFLAMMATION; MALE; PATIENT MONITORING; PRIORITY JOURNAL; BLOOD; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PANCREATITIS;

CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; CYTOKINES; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-2; INTERLEUKIN-4; INTERLEUKIN-6; MALE; MIDDLE AGED; PANCREATITIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 48749099010     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2008/481560     Document Type: Article

References (25)

1. Skude G., Wehlin L., Maruyana T., Ariyama J., Hyperamylasaemia after duodenoscopy and retrograde cholangiopancreatography Gut 1976 17 2 127 132
2. Chen C.-C., Wang S.-S., Lu R.-H., Lu C.-C., Chang F.-Y., Lee S.-D., Early changes of serum proinflammatory and anti-inflammatory cytokines after endoscopic retrograde cholangiopancreatography Pancreas 2003 26 4 375 380
3. Gottlieb K., Sherman S., Pezzi J., Esber E., Lehman G. A., Early recognition of post-ERCP pancreatitis by clinical assessment and serum pancreatic enzymes The American Journal of Gastroenterology 1996 91 8 1553 1557
4. Sultan S., Baillie J., What are the predictors of post-ERCP pancreatitis, and how useful are they? Journal of the Pancreas 2002 3 6 188 194
5. Frossard J.-L., Hadengue A., Pastor C. M., New serum markers for the detection of severe acute pancreatitis in humans American Journal of Respiratory and Critical Care Medicine 2001 164 1 162 170
6. Dinarello C. A., Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist International Reviews of Immunology 1998 16 5-6 457 499
7. Mosmann T. R., Cherwinski H., Bond M. W., Giedlin M. A., Coffman R. L., Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins The Journal of Immunology 1986 136 7 2348 2357
8. Kelso A., Th1 and Th2 subsets: paradigms lost? Immunology Today 1995 16 8 374 379
9. Abbas A. K., Lichtman A. H., Abbas A. K., Lichtman A. H., Cytokines Cellular and Molecular Immunology 2003 5th chapter 11 Philadelphia, Pa, USA Saunders 243 274
10. Abbas A. K., Lichtman A. H., Abbas A. K., Lichtman A. H., Immunity to microbes Cellular and Molecular Immunology 2003 5th chapter 15 Philadelphia, Pa, USA Saunders 345 366
11. Doria A., Iaccarino L., Arienti S., Th2 immune deviation induced by pregnancy: the two faces of autoimmune rheumatic diseases Reproductive Toxicology 2006 22 2 234 241
12. Testoni P. A., Why the incidence of post-ERCP pancreatitis varies considerably? Factors affecting the diagnosis and the incidence of this complication Journal of the Pancreas 2002 3 6 195 201
13. Bradley E. L. III, A clinically based classification system for acute pancreatitis: summary of the International Symposium on Acute Pancreatitis, Atlanta, Ga, September 11 through 13, 1992 Archives of Surgery 1993 128 5 586 590
14. Masci E., Toti G., Mariani A., Complications of diagnostic and therapeutic ERCP: a prospective multicenter study The American Journal of Gastroenterology 2001 96 2 417 423
15. Cheng C.-L., Sherman S., Watkins J. L., Risk factors for post-ERCP pancreatitis: a prospective multicenter study The American Journal of Gastroenterology 2006 101 1 139 147
16. Adbel Aziz A. M., Lehman G. A., Pancreatits after endoscopic retrograde cholangio-pancreatography World Journal of Gastroenterology 2007 13 19 2655 2668
17. Testoni P. A., Bagnolo F., Pain at 24 hours associated with amylase levels greater than 5 times the upper normal limit as the most reliable indicator of post-ERCP pancreatitis Gastrointestinal Endoscopy 2001 53 1 33 39
18. Kaw M., Singh S., Serum lipase, C-reactive protein, and interleukin-6 levels in ERCP-induced pancreatitis Gastrointestinal Endoscopy 2001 54 4 435 440
19. Messmann H., Vogt W., Holstege A., Post-ERP pancreatitis as a model for cytokine induced acute phase response in acute pancreatitis Gut 1997 40 1 80 85
20. Mayer J., Rau B., Gansauge F., Beger H. G., Inflammatory mediators in human acute pancreatitis: clinical and pathophysiological implications Gut 2000 47 4 546 552
21. Chen C.-C., Wang S.-S., Lu R.-H., Chang F.-Y., Lee S.-D., Serum interleukin 10 and interleukin 11 in patients with acute pancreatitis Gut 1999 45 6 895 899
22. Devière J., Le Moine O., Van Laethem J.-L., Interleukin 10 reduces the incidence of pancreatitis after therapeutic endoscopic retrograde cholangiopancreatography Gastroenterology 2001 120 2 498 505
23. Oezcueruemez-Porsch M., Kunz D., Hardt P. D., Diagnostic relevance of interleukin pattern, acute-phase proteins, and procalcitonin in early phase of post-ERCP pancreatitis Digestive Diseases and Sciences 1998 43 8 1763 1769
24. Pezzilli R., Morselli-Labate A. M., Miniero R., Barakat B., Fiocchi M., Cappelletti O., Simultaneous serum assays of lipase and interleukin-6 for early diagnosis and prognosis of acute pancreatitis Clinical Chemistry 1999 45 10 1762 1767
25. Chen P., Yuan Y., Wang S., Zhan L., Xu J., Serum matrix metalloproteinase 9 as a marker for the assessment of severe acute pancreatitis The Tohoku Journal of Experimental Medicine 2006 208 3 261 266